Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Bracco Imaging spa, Via Egidio Folli 50, 20134, Milano Italy
NIOPAM 300, solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear aqueous solution filled into colourless glass ampoules or bottles. |
61.2% w/v Iopamidol equivalent to 300mg iodine/ml. Each contains 612 mg iopamidol.
For the full list of excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Iopamidol |
Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media. |
| List of Excipients |
|---|
|
Excipients are: Trometamol |
10ml clear, colourless type I glass ampoules.
20 and 30ml clear, colourless type I or type II glass vials with rubber closures and aluminium caps.
20, 50, 70, 100, 200 and 250ml clear, colourless type I or type II glass bottles with rubber closures and aluminium caps.
Bracco Imaging spa, Via Egidio Folli 50, 20134, Milano – Italy
PL 12032/0014
22/03/1982 / 05/12/2003
| Drug | Countries | |
|---|---|---|
| NIOPAM | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
